Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial

Mads Israelsen; Emilie Dahl; Bjorn Madsen; Signe Wiese; Flemming Bendtsen; Soren Moller; Annette Dam Fialla; Boye L. Jensen; Aleksander Krag

doi:10.1016/S0618-8278(19)31297-6

Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial

Mads Israelsen, Emilie Dahl, Bjorn Madsen, Signe Wiese, Flemming Bendtsen, Soren Moller, Annette Dam Fialla, Boye L. Jensen, Aleksander Krag

Hvidovre Hospital

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Journal of Hepatology
Volume	70
Issue number	1, Suppl.
Pages (from-to)	E651-E652
ISSN	0168-8278
DOIs	https://doi.org/10.1016/S0618-8278(19)31297-6
Publication status	Published - Apr 2019
Event	The International Liver Congress 2019 - Vienna, Austria Duration: 10. Apr 2019 → 14. Apr 2019

Conference

Conference	The International Liver Congress 2019
Country/Territory	Austria
City	Vienna
Period	10/04/2019 → 14/04/2019

Documents & Links

10.1016/S0618-8278(19)31297-6

Cite this

Israelsen, M., Dahl, E., Madsen, B., Wiese, S., Bendtsen, F., Moller, S., Fialla, A. D., Jensen, B. L., & Krag, A. (2019). Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial. Journal of Hepatology, 70(1, Suppl.), E651-E652. https://doi.org/10.1016/S0618-8278(19)31297-6

@article{af1bb21e2f2c41e78c1d98e412f2cccc,

title = "Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial",

author = "Mads Israelsen and Emilie Dahl and Bjorn Madsen and Signe Wiese and Flemming Bendtsen and Soren Moller and Fialla, {Annette Dam} and Jensen, {Boye L.} and Aleksander Krag",

year = "2019",

month = apr,

doi = "10.1016/S0618-8278(19)31297-6",

language = "English",

volume = "70",

pages = "E651--E652",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier",

number = "1, Suppl.",

note = "The International Liver Congress 2019 ; Conference date: 10-04-2019 Through 14-04-2019",

}

Israelsen, M, Dahl, E, Madsen, B, Wiese, S, Bendtsen, F, Moller, S, Fialla, AD , Jensen, BL & Krag, A 2019, 'Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial', Journal of Hepatology, vol. 70, no. 1, Suppl., pp. E651-E652. https://doi.org/10.1016/S0618-8278(19)31297-6

Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial. / Israelsen, Mads; Dahl, Emilie; Madsen, Bjorn et al.
In: Journal of Hepatology, Vol. 70, No. 1, Suppl., 04.2019, p. E651-E652.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial

AU - Israelsen, Mads

AU - Dahl, Emilie

AU - Madsen, Bjorn

AU - Wiese, Signe

AU - Bendtsen, Flemming

AU - Moller, Soren

AU - Fialla, Annette Dam

AU - Jensen, Boye L.

AU - Krag, Aleksander

PY - 2019/4

Y1 - 2019/4

U2 - 10.1016/S0618-8278(19)31297-6

DO - 10.1016/S0618-8278(19)31297-6

M3 - Conference abstract in journal

SN - 0168-8278

VL - 70

SP - E651-E652

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 1, Suppl.

T2 - The International Liver Congress 2019

Y2 - 10 April 2019 through 14 April 2019

ER -